Once-daily modified-release oxycodone launched

A once-daily prolonged-release oxycodone tablet, Onexila XL, is now available for the treatment of severe pain that can only be managed with opioid analgesics.

Onexila XL provides the equivalent oxycodone dose to existing twice-daily modified-release tablets in half the number of doses. It is intended to help reduce pill burden for patients and healthcare professionals administering the medications.

Available in 10mg, 20mg, 40mg and 80mg tablets, Onexila XL is the first once-daily modified-release oxycodone formulation to become available in the UK.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...